Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Nov 15, 2026; 18(11): 123631
Published online Nov 15, 2026. doi: 10.4251/wjgo.123631
Published online Nov 15, 2026. doi: 10.4251/wjgo.123631
Table 1 Participant baseline characteristics stratified by low muscle mass, n (%)/mean ± SD
| Characteristics | Overall | NMM | LMM | P value |
| n | 105 | 57 | 48 | - |
| Sex | 0.001 | |||
| Female | 18 (17.1) | 16 (15.2) | 2 (1.9) | |
| Male | 87 (82.9) | 41 (39) | 46 (43.8) | |
| Age, median (IQR) | 65 (58, 69) | 66 (61, 69) | 64 (58, 69) | 0.434 |
| Smoking history | 0.002 | |||
| No | 34 (32.4) | 26 (24.8) | 8 (7.6) | |
| Yes | 71 (67.6) | 31 (29.5) | 40 (38.1) | |
| Alcoholhistory | 0.075 | |||
| No | 38 (36.2) | 25 (23.8) | 13 (12.4) | |
| Yes | 67 (63.8) | 32 (30.5) | 35 (33.3) | |
| Tumorlocation | 0.825 | |||
| Cervical | 15 (14.3) | 9 (8.6) | 6 (5.7) | |
| Upper thoracic | 26 (24.8) | 15 (14.3) | 11 (10.5) | |
| Middle thoracic | 43 (41.0) | 21 (20.0) | 22 (21.0) | |
| Lower thoracic | 21 (20.0) | 12 (11.4) | 9 (8.6) | |
| T | 0.212 | |||
| 1 | 1 (1.0) | 0 (0.0) | 1 (1.0) | |
| 2 | 3 (2.9) | 3 (2.9) | 0 (0.0) | |
| 3 | 89 (84.8) | 49 (46.7) | 40 (38.1) | |
| 4 | 12 (11.4) | 5 (4.8) | 7 (6.7) | |
| N | 0.051 | |||
| 0 | 1 (1.0) | 1 (1.0) | 0 (0.0) | |
| 1 | 17 (16.2) | 13 (12.4) | 4 (3.8) | |
| 2 | 63 (60.0) | 34 (32.4) | 29 (27.6) | |
| 3 | 24 (22.9) | 9 (8.6) | 15 (14.3) | |
| TNM | 0.482 | |||
| III | 82 (78.1) | 46 (43.8) | 36 (34.3) | |
| IV | 23 (21.9) | 11 (10.5) | 12 (11.4) | |
| WBC, median (IQR) | 6.05 (5.13, 7.27) | 6.02 (5.15, 7.42) | 6.05 (5.07, 7.24) | 0.714 |
| HGB, median (IQR) | 130 (120, 141) | 133 (120, 141) | 127 (120, 138) | 0.214 |
| PLT, median (IQR) | 199 (159, 237) | 194 (147, 233) | 205.5 (161, 250) | 0.320 |
| NC, median (IQR) | 4.10 (3.05, 5.24) | 4.11 (3.15, 5.28) | 4.09 (2.95, 5.22) | 0.700 |
| LC | 1.36 ± 0.48 | 1.35 ± 0.46 | 1.37 ± 0.51 | 0.841 |
| MC, median (IQR) | 0.43 (0.32, 0.52) | 0.425 (0.31, 0.56) | 0.44 (0.32, 0.50) | 0.860 |
| ALB | 38.20 ± 3.28 | 38.92 ± 3.35 | 37.35 ± 3.00 | 0.014 |
| PA | 195.11 ± 46.84 | 203.05 ± 51.46 | 185.67 ± 39.13 | 0.058 |
| Triglycerides, median (IQR) | 1.15 (0.93, 1.44) | 1.19 (1, 1.47) | 1.035 (0.86, 1.29) | 0.016 |
| Total cholesterol, median (IQR) | 4.44 (3.76, 5.07) | 4.65 (4.04, 5.28) | 4.33 (3.72, 4.85) | 0.189 |
| Blood glucose, median (IQR) | 4.82 (4.46, 5.13) | 4.92 (4.56, 5.25) | 4.675 (4.44, 4.97) | 0.060 |
| RT dose, median (IQR) | 60 (60, 60) | 60 (56, 60) | 60 (60, 60) | 0.561 |
| BMI | < 0.001 | |||
| < 18.5 kg/m2 | 7 (6.7) | 0 (0) | 7 (6.7) | |
| 18.5-24.0 kg/m2 | 70 (66.7) | 35 (33.3) | 35 (33.3) | |
| ≥ 24.0 kg/m2 | 28 (26.7) | 22 (21) | 6 (5.7) | |
- Citation: Xiao L, Li LJ, Lyu JH, Zhang SC, Liang L. Combined low muscle mass and body mass index for prognosis in esophageal squamous cell carcinoma patients receiving immunochemoradiotherapy. World J Gastrointest Oncol 2026; 18(11): 123631
- URL: https://www.wjgnet.com/1948-5204/full/v18/i11/123631.htm
- DOI: https://dx.doi.org/10.4251/wjgo.123631